Dombret H - Search Results

1

Granulomonocytic progenitors are key target cells of azacytidine in higher risk myelodysplastic syndromes and acute myeloid leukemia.

Ali A, Penneroux J, Dal Bello R Jr, Massé A, Quentin S, Unnikrishnan A, Hernandez L, Raffoux E, Ben Abdelali R, Renneville A, Preudhomme C, Pimanda J, Dombret H, Soulier J, Fenaux P, Clappier E, Adès L, Puissant A, Itzykson R. Ali A, et al. Among authors: dombret h. Leukemia. 2018 Aug;32(8):1856-1860. doi: 10.1038/s41375-018-0076-2. Epub 2018 Feb 26. Leukemia. 2018. PMID: 29535430 No abstract available.

2

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.

Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, et al. Fenaux P, et al. Among authors: dombret h. Blood. 1992 Nov 1;80(9):2176-81. Blood. 1992. PMID: 1421389 Free article. Clinical Trial.

3

All trans retinoic acid treatment for patients with acute promyelocytic leukemia.

Fenaux P, Castaigne S, Chomienne C, Dombret H, Degos L. Fenaux P, et al. Among authors: dombret h. Leukemia. 1992;6 Suppl 1:64-6. Leukemia. 1992. PMID: 1548938 Review. No abstract available.

4

All trans retinoic acid in acute promyelocytic leukemia.

Degos L, Castaigne S, Fenaux P, Daniel MT, Dombret H, Chomienne C. Degos L, et al. Among authors: dombret h. Nouv Rev Fr Hematol (1978). 1991;33(2):183-5. Nouv Rev Fr Hematol (1978). 1991. PMID: 1766850 Review. No abstract available.

5

In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.

Dombret H, Scrobohaci ML, Daniel MT, Micléa JM, Castaigne S, Chomienne C, Fenaux P, Degos L. Dombret H, et al. Leukemia. 1995 Jan;9(1):19-24. Leukemia. 1995. PMID: 7531260

6

Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?

Dombret H, Geiger S, Daniel MT, Glaisner S, Micléa JM, Castaigne S, Merle-Beral H, Lacombe C, Chomienne C, Degos L. Dombret H, et al. Leukemia. 1995 Sep;9(9):1473-7. Leukemia. 1995. PMID: 7658714

7

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastang C, Castaigne S, Fenaux P. Degos L, et al. Among authors: dombret h. Blood. 1995 May 15;85(10):2643-53. Blood. 1995. PMID: 7742522 Free article. Review. No abstract available.

8

Induction treatment of acute promyelocytic leukemia using all-trans retinoic acid. Controversies about dosage, advantages and side-effect management.

Dombret H, Castaigne S, Fenaux P, Chomienne C, Degos L. Dombret H, et al. Leukemia. 1994;8 Suppl 3:S73-5. Leukemia. 1994. PMID: 7808030 Clinical Trial.

9

Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.

Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L. Dombret H, et al. Leukemia. 1993 Jan;7(1):2-9. Leukemia. 1993. PMID: 8418375

10

All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia.

Seale J, Delva L, Renesto P, Balitrand N, Dombret H, Scrobohaci ML, Degos L, Paul P, Chomienne C. Seale J, et al. Among authors: dombret h. Leukemia. 1996 Jan;10(1):95-101. Leukemia. 1996. PMID: 8558945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters